NDC 71225-114
Icatibant
Icatibant
Icatibant is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Slayback Pharma Llc. The primary component is Icatibant Acetate.
| Product ID | 71225-114_5ccd1185-cbec-4c7f-a654-95f8ff1a7e01 |
| NDC | 71225-114 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Icatibant |
| Generic Name | Icatibant |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2020-09-03 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211501 |
| Labeler Name | Slayback Pharma LLC |
| Substance Name | ICATIBANT ACETATE |
| Active Ingredient Strength | 30 mg/3mL |
| Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |